Marty W. Mayo

17.1k citations

70 papers · 14.5k indexed · 7 hit papers · h-index 41

Molecular Biology top 0.5%
Cancer Research top 0.1%
Immunology top 0.5%
Oncology top 0.5%
Epidemiology top 2%

Co-authors: Albert S. Baldwin Cun-Yu Wang Lee V. Madrid David V. Goeddel Robert G. Korneluk David R. Jones Fan Yeung Denis C. Guttridge
Topics: NF-κB Signaling Pathways (31 papers)Cell death mechanisms and regulation (11 papers)interferon and immune responses (7 papers)
Cited by: Cancer Research Geriatrics and Gerontology Immunology
Journals: Science Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Germany France

In The Last Decade

Marty W. Mayo

65 papers receiving 14.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation

1998 2.4k citations Marty W. Mayo, Albert S. Baldwin et al. profile →
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB

1996 2.4k citations Marty W. Mayo, Albert S. Baldwin et al. profile →
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase

2004 2.3k citations Fan Yeung, David R. Jones et al. The EMBO Journal profile →
NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia

2000 763 citations Marty W. Mayo, Lee V. Madrid et al. profile →
Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38

2001 686 citations Lee V. Madrid, Marty W. Mayo et al. Journal of Biological Chemistry profile →
Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB

2000 572 citations Lee V. Madrid, Albert S. Baldwin et al. profile →
NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis

1999 521 citations Marty W. Mayo, Albert S. Baldwin et al. profile →

Peers

Countries citing papers authored by Marty W. Mayo

Since Specialization

Citations

This map shows the geographic impact of Marty W. Mayo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marty W. Mayo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marty W. Mayo more than expected).

Fields of papers citing papers by Marty W. Mayo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marty W. Mayo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marty W. Mayo. The network helps show where Marty W. Mayo may publish in the future.

Co-authorship network of co-authors of Marty W. Mayo

This figure shows the co-authorship network connecting the top 25 collaborators of Marty W. Mayo. A scholar is included among the top collaborators of Marty W. Mayo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marty W. Mayo. Marty W. Mayo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of DHX36/G4R1, a G4 resolvase, drives genome instability and regulates innate immune gene expression in cancer cells 2025 ·Nucleic Acids Research ·Anna Bartosik,Pei‐Chi Hou,Shangming Tang,James P. Vaughn,Philip J. Smaldino,Aakrosh Ratan,Marty W. Mayo,Yuh‐Hwa Wang	0
2	Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer 2020 ·Cancer Research ·Piotr Przanowski,Song Lou,(unknown),Tanmoy Mondal,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Marty W. Mayo,Luís Teixeira,Jacqueline Lehmann‐Che,(unknown),Sanchita Bhatnagar	23
3	Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-κB Activation 2020 ·Cancer Research ·Shekhar Saha,Manjari Kiran,Canan Kuscu,Ajay Chatrath,David Wotton,Marty W. Mayo,Anindya Dutta	56
4	The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma 2020 ·Journal of Thoracic Oncology ·Raul Caso,Francisco Sánchez-Vega,Kay See Tan,Brooke Mastrogiacomo,Jian Zhou,Gregory D. Jones,Bastien Nguyen,Nikolaus Schultz,James G. Connolly,Whitney S. Brandt,Matthew J. Bott,Gaetano Rocco,Daniela Molena,James M. Isbell,Yuan Liu,Marty W. Mayo,Prasad S. Adusumilli,William D. Travis,David R. Jones	96
5	A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer 2018 ·Cancer Cell ·(unknown),(unknown),Piotr Przanowski,Justin S. A. Perry,James O. Jones,(unknown),(unknown),(unknown),Edward B. Stelow,Yuliya Petrova,Danielle C. Llaneza,Marty W. Mayo,Kodi S. Ravichandran,Charles N. Landen,Sanchita Bhatnagar,(unknown)	30
6	The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK 2017 ·Science Signaling ·Elianna Amin,Yuan Liu,Su Deng,Kay See Tan,Neel P. Chudgar,Marty W. Mayo,Francisco Sánchez-Vega,Prasad S. Adusumilli,Nikolaus Schultz,David R. Jones	56
7	CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation 2016 ·Cancer Research ·Yuan Liu,(unknown),Marty W. Mayo,Neel P. Chudgar,(unknown),Kyuichi Kadota,Prasad S. Adusumilli,David R. Jones	28
8	Activin Upregulation by NF-κB Is Required to Maintain Mesenchymal Features of Cancer Stem–like Cells in Non–Small Cell Lung Cancer 2014 ·Cancer Research ·(unknown),(unknown),David F. Allison,(unknown),(unknown),(unknown),Stephen A. Hoang,Xiaojiang Xu,Christopher A. Moskaluk,David R. Jones,Stefan Bekiranov,Marty W. Mayo	61
9	Inhibition of Breast Cancer Metastasis Suppressor 1 Promotes a Mesenchymal Phenotype in Lung Epithelial Cells That Express Oncogenic K-RasV12 and Loss of p53 2014 ·PLoS ONE ·Emily H. Hall,Yuan Liu,Aizhen Xiao,Lisa S. Shock,David L. Brautigan,Marty W. Mayo,Prasad S. Adusumilli,David R. Jones	9
10	BRMS1 Suppresses Lung Cancer Metastases through an E3 Ligase Function on Histone Acetyltransferase p300 2012 ·Cancer Research ·Yuan Liu,Marty W. Mayo,Alykhan S. Nagji,Emily H. Hall,Lisa S. Shock,Aizhen Xiao,Edward B. Stelow,David R. Jones	36
11	Global Epigenetic Changes Induced by SWI2/SNF2 Inhibitors Characterize Neomycin-Resistant Mammalian Cells 2012 ·PLoS ONE ·(unknown),(unknown),(unknown),Shyamal K. Goswami,Sneha Sudha Komath,Marty W. Mayo,Joel W. Hockensmith,Rohini Muthuswami	22
12	The promoter for intestinal cell kinase is head-to-head with F-Box 9 and contains functional sites for TCF7L2 and FOXA factors 2010 ·Molecular Cancer ·Thomas W. Sturgill,(unknown),Steven M. Cohn,Marty W. Mayo	10
13	LZAP, a Putative Tumor Suppressor, Selectively Inhibits NF-κB 2007 ·Cancer Cell ·Jialiang Wang,Hanbing An,Marty W. Mayo,Albert S. Baldwin,Wendell G. Yarbrough	81
14	COMMD Proteins, a Novel Family of Structural and Functional Homologs of MURR1 2005 ·Journal of Biological Chemistry ·Ezra Burstein,(unknown),Amanda S. Wilkinson,Julie M. Rumble,Rebecca A. Csomos,Christine M. Komarck,Gabriel N. Maine,John Wilkinson,Marty W. Mayo,Colin S. Duckett	212
15	SMRT Derepression by the IκB Kinase α 2004 ·Molecular Cell ·(unknown),Fan Yeung,Marty W. Mayo	184
16	PTEN Blocks Tumor Necrosis Factor-induced NF-κB-dependent Transcription by Inhibiting the Transactivation Potential of the p65 Subunit 2002 ·Journal of Biological Chemistry ·Marty W. Mayo,Lee V. Madrid,Sandy D. Westerheide,David R. Jones,Xiu‐Juan Yuan,Albert S. Baldwin,Young E. Whang	107
17	Ras regulation of NF-KB and apoptosis 2001 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Marty W. Mayo,Jacqueline L. Norris,Albert S. Baldwin	67
18	Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38breakdown → 2001 ·Journal of Biological Chemistry ·Lee V. Madrid,Marty W. Mayo,(unknown),Albert S. Baldwin	686
19	The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance 2000 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Marty W. Mayo,Albert S. Baldwin	280
20	WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene 1999 ·The EMBO Journal ·Marty W. Mayo,Cun‐Yu Wang,Simon Drouin,Lee V. Madrid,Allen F. Marshall,John C. Reed,Bernard E. Weissman,Albert S. Baldwin	202

About Marty W. Mayo

Marty W. Mayo is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 70 papers that have together received 14.5k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (31 papers), Cell death mechanisms and regulation (11 papers) and interferon and immune responses (7 papers). The work is most often cited by research in Cancer Research (5.6k citations), Geriatrics and Gerontology (1.4k citations) and Immunology (3.8k citations). Marty W. Mayo has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Albert S. Baldwin, Cun-Yu Wang, Lee V. Madrid, David V. Goeddel, Robert G. Korneluk, David R. Jones, Fan Yeung, Denis C. Guttridge, Michael D. Keller and Roy A. Frye. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact